January 31st, 2014
A (Not So) New Drug Landscape for Pulmonary Arterial Hypertension
John Ryan, MD
John Ryan offers a primer on three newly approved drugs for pulmonary arterial hypertension.
NEJM Journal Watch — Recent Cardiology Articles- No Effect of Omecamtiv Mecarbil on Exercise Intolerance in Heart Failure with Reduced Ejection Fraction
- Better Cardiorespiratory Fitness Is Associated with Lower Mortality Risk at All Ages
- Hypothermia Isn't Better Than Normothermia After Cardiac Arrest
- Does Dual Antiplatelet Therapy Reduce Early Surgical Saphenous Vein Graft Failure?
- Risk of Noncardiac Surgery After TAVR